COT 2022 meeting notes
Last updated: 21 April 2022
At their February meeting the Committee discussed items including lead in the maternal diet, the draft 2021 Annual Report, Horizon Scanning and a first draft statement on the risk assessment of cow’s milk in children aged 1 to 5 years, in the context of the plant-based drinks evaluations. They also discussed Aflatoxin in foodstuffs and Vitamin D in infant formula. The Committee continued to work on the 2nd draft statement on the effects of excess Vitamin A on maternal health.
At their Extraordinary meeting, the Committee discussed the re-evaluation presented in the EFSA Draft Opinion on BPA which has been published for public consultation.
The Committee reviewed papers covering: a Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs , methods and weight of evidence, Benchmark dose modelling (including uncertainty analysis and derivation of the HBGV), Hazard characterisation and specific endpoints including Immunotoxicity, Reproductive and Developmental toxicity, Neurotoxicity and Developmental Neurotoxicity, Genotoxicity and they also had a general discussion on other aspects of the evaluation.
Readers should note that the papers on the website have not undergone all the normal review processes due to the short deadlines and are reminded that they are discussion papers, they are not the final views of the Committee and should not be cited.
At their March meeting the Committee discussed items including the potential risk to human health of turmeric and curcumin supplements, potential approaches to mixture risk assessment for future UK REACH assessments and an updated discussion paper on the bioavailability of nicotine and other ingredients from the use of oral nicotine pouches and the first draft of a statement on the effects of cadmium on maternal health. The Committee continued work on draft statements considering the effects of excess Vitamin A in the maternal diet and on the risk assessment of cow’s milk in children aged 1 to 5 years, in the context of the plant-based drinks evaluations.